SCHEMBL17757259

SCHEMBL17757259

NC(=O)CNc1ncc2c(n1)NC1(CCNCC1)C(NCc1cccc(Cl)c1)=N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ VNN1 O95497 3/20 0.39
▸ CCNT1 O60563 1/20 0.37
▸ STAT6 P42226 1/20 0.36
▸ PRKCQ Q04759 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ RPS6KB1 P23443 3/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ ACAT2 Q9BWD1 1/20 0.34
▸ CD38 P28907 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757254 0.87 HDAC3 (0.40) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17757975 0.80 ACAT2 (0.39) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17757482 0.80 ACAT2 (0.39) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17757318 0.77 VNN1 (0.44) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17757777 0.77 CD38 (0.44) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17758134 0.77 CCNT1 (0.39) CCNT1RPS6KB1MAOBHTR6ACAT2
SCHEMBL17758135 0.77 HRH4 (0.38) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL17757760 0.77 ACAT2 (0.44) HDAC3HDAC1HDAC2HDAC6VNN1
SCHEMBL21982521 0.76 CCNT1 (0.37) HDAC3HDAC1HDAC2HDAC6CCNT1
SCHEMBL17757784 0.76 VNN1 (0.43) HDAC3HDAC1HDAC2HDAC6VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 HDAC3 771/4885HDAC1 942/4885HDAC2 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback